C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL

TEMESGEN Z., BURGER C., BAKER J., POLK C., LIBERTIN C., KELLEY C., MARCONI V., ORENSTEIN R., CATTERSON V., ARONSTEIN W., DURRANT C., CHAPPELL D., CHAPPELL G., AHMED O., BADLEY A.

DOI

10.1016/j.chest.2021.08.029

Type

Journal article

Journal

Chest

Publisher

Elsevier BV

Publication Date

10/2021

Volume

160

Pages

A2522 - A2524

Permalink Original publication